<DOC>
	<DOCNO>NCT01614132</DOCNO>
	<brief_summary>The purpose study determine whether combination radiochemotherapy ( vincristin ) follow maintenance chemotherapy ( vincristin , cisplatin CCNU ) adult patient medulloblastoma tolerable .</brief_summary>
	<brief_title>Multicenter Pilot-study Therapy Medulloblastoma Adults</brief_title>
	<detailed_description>As medulloblastoma adult patient rare ( 1.1 % brain tumor ) , adult often treat scope expand access treatment within pediatric study ; although , know whether medulloblastomas act way adulthood childhood . This first study investigate significance combination radiochemotherapy ( vincristin ) follow maintenance chemotherapy ( vincristin , cisplatin CCNU ) adult patient medulloblastoma purpose start point development chemotherapeutical protocol adult .</detailed_description>
	<mesh_term>Medulloblastoma</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Lomustine</mesh_term>
	<criteria>age &gt; 18 year medulloblastoma ( +/ postoperative residual tumor , M0 ) medulloblastoma ( +/ postoperative residual tumor , M1M3 ) respectively primary diagnosis tumor previous chemo radiation therapy KarnofskyIndex ≥ 70 % WBC ≥ 3000/μl ; thrombocyte ≥ 100 000/μl ; Hb ≥ 10 g/dl creatinine = &lt; 1,5 ULN ; Bilirubin = &lt; 1,5 ULN ; GPT , GOT , AP = &lt; 2,5 ULN HIV hepatitis B/C negative factor / medical condition affect patient 's compliance patient need fulfil protocol 's requirement patient willing use highly effective method contraception dose 6 month last dose ; woman childbearing potential must negative hCG laboratory test baseline ; pregnancy test must repeat every 4 week patient 's write consent age &lt; 18 year histologically confirm Medulloblastoma chemo radiotherapy treat recidive tumor cancer ( exception surgically cure carcinoma situ cervix nonmelanocytic skin tumor ) hypersensitivity contraindication one use drug current plan participation another clinical trial study Any condition , opinion Investigator , would make patient unsuitable enrolment could interfere patient participate complete study Any medical condition associate high medical risk contraindicate use chemotherapeutic agent indicate current product package insert Pregnant nursing ( lactate ) woman ; woman men willing use highly effective method contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>medulloblastoma</keyword>
	<keyword>CNS</keyword>
	<keyword>malignant neoplasm</keyword>
	<keyword>NOA</keyword>
	<keyword>neuroectodermal tumor</keyword>
	<keyword>Vincristin</keyword>
	<keyword>CCNU</keyword>
	<keyword>Cisplatin</keyword>
</DOC>